Form 144 | Incyte(INCY.US) Officer Proposes to Sell 488.88K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 9, $Incyte(INCY.US)$ Officer BARRY FLANNELLY intends to sell 8,148 shares of its common stock on Jul 9, with a total market value of approximately $488.88K. BARRY
S&P 500, Nasdaq Set New Closing Records After Fed Chair Powell's Comments
The S&P 500 and the Nasdaq Composite closed at new record highs Tuesday after Federal Reserve Chair Jerome Powell said inflation seems to have improved in recent months, though the job is not done
S&P 500 Hits Record Highs, Eyes 6th Straight Gain As Powell Keeps Bears At Bay; Tesla Targets 10th Consecutive Win, Bank Stocks Rally: What's Driving Markets Tuesday?
The S&P 500 index climbed to new all-time highs, rising 0.3% during Tuesday's session, aiming for a potential sixth consecutive positive close and remaining resilient after Fed Chair Jerome Powell's
Incyte to Report Second Quarter Financial Results
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 30, 202
Express News | Incyte Corp : RBC Raises Target Price to $61 From $60
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Incyte (NASDAQ:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 14,577 shares of the Company's common stock and stock option awards to purchase an aggregate of
Notable Analyst Calls This Week: Nvidia, Spirit Airlines and PayPal Among Top Picks
Express News | Incyte Corp - on June 28, Co, Unit Entered Amendment No. 2 to Revolving Credit and Guaranty Agreement Dated as of August 21, 2021
Express News | Incyte Corp - Extended the Maturity Date of the Revolving Credit Facility Under the Existing Credit Agreement From August 18, 2024 to June 28, 2027
S&P 500, Nasdaq Close at Record Highs After Fed Chair Powell's Comments
The S&P 500 and the Nasdaq Composite closed at record highs Tuesday after Federal Reserve Chair Jerome Powell said policymakers have made "quite a bit of progress" against inflation. The tech-heavy Na
Sector Update: Health Care Stocks Retreat Tuesday Afternoon
Health care stocks were declining Tuesday afternoon, with the NYSE Health Care Index shedding 0.8% and the Health Care Select Sector SPDR Fund (XLV) down 0.7%. The iShares Biotechnology ETF (IBB) fell
This CrowdStrike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Incyte Drops as BMO Downgrades on $2B Buybacks
Today's Morning Movers and Top Ratings: PARA, CRWD, LEN, PYPL and More
CrowdStrike's stock decreased by 2.36% after Piper Sandler changed its rating on the cybersecurity company to "neutral" from "overweight," mentioning valuation concerns.
Express News | Incyte Shares Are Trading Lower After BMO Capital Downgraded the Stock From Market Perform to Underperform and Lowered Its Price Target From $52 to $48
Express News | Incyte Corp : BMO Cuts Target Price to $48 From $52
Express News | Incyte Corp : BMO Cuts to Underperform From Market Perform
Express News | Incyte Shares Down 3% Premarket; BMO Downgrades to "Underperform" From "Market Perform", as per Thefly.com
BMO Capital Downgrades Incyte(INCY.US) to Sell Rating, Cuts Target Price to $48
BMO Capital analyst Evan Seigerman downgrades $Incyte(INCY.US)$ to a sell rating, and adjusts the target price from $56 to $48.According to TipRanks data, the analyst has a success rate of 51.1% and a
Incyte Cut to Underperform From Market Perform by BMO Capital
Incyte Cut to Underperform From Market Perform by BMO Capital